To Enrich Big Pharma, FDA and DEA Deny Science on Medical Marijuana
It would be unreasonable, arbitrary and capricious for DEA to stand between sufferers and the benefits of this substance in light of the evidence.
It would be unreasonable, arbitrary and capricious for DEA to stand between sufferers and the benefits of this substance in light of the evidence.
Judge Charles R. Breyer said that the DEA’s interpretation of the bipartisan medical marijuana bill “defied logic and language”
If the DEA had been paying any heed to the mountain of medical research by experts in managing pain, it would have learned that what Americans in pain need most is not more prescription pain killers, but better access to medicinal marijuana; that common weed that is empirically proven to reduce opioid use and save countless thousands of Americans’ lives every year.
One thing is certain, if Fiorina’s knowledge, or lack thereof, of the tremendous medical advances and research verifying the many, many medical benefits of cannabis is anything like her knowledge of running a giant tech business, it is no wonder she is an epic failure.